CliffBio
small molecule

ETHAMOLIN

ETHANOLAMINE OLEATE

Loss of exclusivity—loss of exclusivity
CompanyQOL Medical →See this company's full patent-cliff portfolio

Drug detail

Brand nameETHAMOLIN
Active ingredientETHANOLAMINE OLEATE
Strength50MG/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalDecember 1988
Marketing statusRX

More from QOL Medical

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ETHAMOLIN patent cliff — loss of exclusivity — | CliffBio